2022•Metabolic Brain DiseaseRequires access

Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons

Mona Dastgheib, Seyed Vahid Shetab-Boushehri, Maryam Baeeri, Mahdi Gholami, Mohammad Yahya Karimi, Asieh Hosseini

Open publisher page 17 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Pentoxifylline, Rolipram, Medicine, Dorsal root ganglion, Oxidative stress, Phosphodiesterase inhibitor, Pharmacology, Phosphodiesterase

Back to paper search Browse research topics Original source

Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons — Research Paper | ScholarLens